JY
PJP icon

Jeff Yass’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Jeff Yass’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$492K Buy
+4,151
New +$449K ﹤0.01% 9962
2025
Q3 		– Sell
-6,825
Closed -$545K – 13554
2025
Q2 		$545K Sell
6,825
-3,686
-35% -$294K ﹤0.01% 8976
2025
Q1 		$910K Buy
10,511
+1,791
+21% +$153K ﹤0.01% 7487
2024
Q4 		$720K Sell
8,720
-2,499
-22% -$215K ﹤0.01% 7754
2024
Q3 		$976K Buy
+11,219
New +$960K ﹤0.01% 6840
2024
Q2 		– Sell
-9,332
Closed -$748K – 12953
2024
Q1 		$748K Sell
9,332
-2,637
-22% -$204K ﹤0.01% 7562
2023
Q4 		$911K Buy
11,969
+2,533
+27% +$181K ﹤0.01% 7209
2023
Q3 		$683K Buy
+9,436
New +$723K ﹤0.01% 7500
2023
Q2 		– Sell
-5,161
Closed -$394K – 12874
2023
Q1 		$392K Sell
5,161
-1,217
-19% -$93.8K ﹤0.01% 9140
2022
Q4 		$501K Sell
6,378
-12,421
-66% -$955K ﹤0.01% 7868
2022
Q3 		$1.34M Buy
18,799
+15,663
+499% +$1.17M ﹤0.01% 5873
2022
Q2 		$235K Sell
3,136
-16,965
-84% -$1.29M ﹤0.01% 10225
2022
Q1 		$1.6M Buy
20,101
+6,242
+45% +$484K ﹤0.01% 5979
2021
Q4 		$1.12M Sell
13,859
-7,690
-36% -$608K ﹤0.01% 6986
2021
Q3 		$1.67M Buy
21,549
+12,764
+145% +$1.03M ﹤0.01% 6232
2021
Q2 		$707K Buy
+8,785
New +$698K ﹤0.01% 8721
2021
Q1 		– Sell
-17,864
Closed -$1.39M – 12699
2020
Q4 		$1.28M Sell
17,864
-18,635
-51% -$1.25M ﹤0.01% 6110
2020
Q3 		$2.33M Buy
36,499
+24,276
+199% +$1.59M ﹤0.01% 4330
2020
Q2 		$791K Sell
12,223
-15,298
-56% -$951K ﹤0.01% 6415
2020
Q1 		$1.51M Sell
27,521
-4,853
-15% -$296K ﹤0.01% 4483
2019
Q4 		$2.1M Sell
32,374
-14,110
-30% -$859K ﹤0.01% 4249
2019
Q3 		$2.63M Buy
+46,484
New +$2.67M ﹤0.01% 3713
2019
Q2 		– Sell
-41,978
Closed -$2.74M – 10682
2019
Q1 		$2.74M Sell
41,978
-6,456
-13% -$424K ﹤0.01% 3275
2018
Q4 		$3.02M Buy
48,434
+40,933
+546% +$2.76M ﹤0.01% 2927
2018
Q3 		$551K Sell
7,501
-4,651
-38% -$334K ﹤0.01% 6343
2018
Q2 		$817K Sell
12,152
-1,306
-10% -$84K ﹤0.01% 5776
2018
Q1 		$840K Sell
13,458
-27,128
-67% -$1.79M ﹤0.01% 5619
2017
Q4 		$2.6M Buy
40,586
+14,930
+58% +$957K ﹤0.01% 3464
2017
Q3 		$1.68M Sell
25,656
-150
-0.6% -$9.47K ﹤0.01% 4237
2017
Q2 		$1.62M Buy
25,806
+424
+2% +$25.5K ﹤0.01% 4298
2017
Q1 		$1.49M Buy
25,382
+14,402
+131% +$842K ﹤0.01% 4290
2016
Q4 		$615K Buy
10,980
+544
+5% +$31.3K ﹤0.01% 6554
2016
Q3 		$643K Sell
10,436
-1,136
-10% -$74.4K ﹤0.01% 5593
2016
Q2 		$733K Sell
11,572
-68,275
-86% -$4.29M ﹤0.01% 5450
2016
Q1 		$4.8M Buy
79,847
+70,290
+735% +$4.3M ﹤0.01% 2356
2015
Q4 		$669K Sell
9,557
-23,035
-71% -$1.63M ﹤0.01% 6230
2015
Q3 		$2.16M Buy
32,592
+29,605
+991% +$2.3M ﹤0.01% 4123
2015
Q2 		$234K Sell
2,987
-14,346
-83% -$1.12M ﹤0.01% 9011
2015
Q1 		$1.32M Buy
+17,333
New +$1.27M ﹤0.01% 5184
2014
Q4 		– Sell
-26,945
Closed -$1.79M – 9978
2014
Q3 		$1.72M Buy
+26,945
New +$1.66M ﹤0.01% 4875
2014
Q2 		– Sell
-35,119
Closed -$2.04M – 10015
2014
Q1 		$1.99M Sell
35,119
-5,972
-15% -$339K ﹤0.01% 4370
2013
Q4 		$2.2M Buy
41,091
+24,362
+146% +$1.22M ﹤0.01% 4114
2013
Q3 		$770K Sell
16,729
-20,019
-54% -$913K ﹤0.01% 5731
2013
Q2 		$1.55M Buy
+36,748
New +$1.53M ﹤0.01% 4305

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Jeff Yass's PJP Position: Q2 2026 in Review

Jeff Yass opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q2 2026: 4,151 shares worth $492K. The stake represents ﹤0.01% of the portfolio and ranks #9962 among its holdings. This is a return to the name: Jeff Yass previously reported a position in PJP as recently as Q2 2025.

Jeff Yass first reported a position in PJP in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.8M in Q1 2016. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Jeff Yass held 4,151 shares of Invesco Pharmaceuticals ETF worth $492K as of Q2 2026.
  • Invesco Pharmaceuticals ETF was a new Jeff Yass position in Q2 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9962 holding.
  • Jeff Yass first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 44 quarters since.
  • Jeff Yass's Invesco Pharmaceuticals ETF position peaked at $4.8M in Q1 2016.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.